Browse > Article

GyeongshinhaeGihwan T1 has Controlling Effects on the Factors Associated with Obesity  

An, Hyo-Jin (College of Oriental Medicine, Kyung Hee University, College of Pharmacy, Wonkwang University)
Choi, In-Young (College of Oriental Medicine, Kyung Hee University, College of Pharmacy, Wonkwang University)
Jung, Yang-Sam (College of Oriental Medicine and Research Institute of Oriental Medicine, Dongeui University)
Yoon, Ki-Hyeon (College of Oriental Medicine and Research Institute of Oriental Medicine, Dongeui University)
Kim, Hyung-Min (College of Oriental Medicine, Kyung Hee University)
Hong, Seung-Heon (College of Pharmacy, Wonkwang University)
Shin, Soon-Shik (College of Oriental Medicine, Kyung Hee University)
Publication Information
Biomolecules & Therapeutics / v.13, no.1, 2005 , pp. 7-12 More about this Journal
Abstract
GyeongshinhaeGihwan T1 (GGT1) is a newly developed oriental medicine to help weight control. We investigated nitric oxide production and cytokine secretion in mouse peritoneal macrophages. According to recent reports, macrophages are participated in fat accumulation and closely related with obesity. In this study, using mouse peritoneal macrophages, we have examined whether GGT1 affects the production of nitric oxide (NO), tumor necrosis factor-${\alpha}$ (TNF-${\alpha}$), and interleukin (IL)-12 by the stimulation of interferon-${\gamma}$ and lipopolysaccharide (LPS). GGT1 inhibits LPS-induced NO production in a dose-dependent manner. The decrease in NO synthesis was reflected as a decreased amount of inducible NO synthese protein. We also found that GGT1 inhibits pro-inflammatory cytokines, TNF-${\alpha}$ and IL-12 production. In mouse embryo preadipocyte 3T3-L1, GGT1 reduced the viability in a dose-dependent manner. These findings suggest that GGT1 may have potential effects in preventing and controlling adipogenesis and obesity.
Keywords
GyeongshinhaeGihwan T1; peritoneal macrophages; preadipocyte; obesity; nitric oxide; cytokine;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Barnes, P.J. (2003) Cytokine-directed therapies for the treatment of chronic airway diseases. Cytokine Growth Factor Rev, 14, 511-522   DOI   ScienceOn
2 Bastard, J.P., Jardel, C., Bruckert, E., Blondy, P., Capeau, J., Laville, M., Vidal, H. and Hainque, B. (2000) Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab, 85, 3338-3342   DOI   ScienceOn
3 Chung, H.S., An, H.J., Jeong, H.J., Won, J.H., Hong, S.H. and Kim, H.M. (2004) Water extract isolated from Chelidonium majus enhances nitric oxide and tumour necrosis factor-alpha production via nuclear factor-kappaB activation in mouse peritoneal macrophages. J Pharm Pharmacol, 56, 129-134   DOI   ScienceOn
4 Hotamisligil, G.S., Shargill, N.S. and Spiegelman, B.M. (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science, 259, 87-91   DOI   ScienceOn
5 Jeong, H.J., Chung, H.S., An, H.J., Seo, S.W., Kim, T.G., Won, J.H., Shin, J.Y., Ahn, K.S. and Kim, H.M. (2004) The immune-enhancing effect of the herbal combination Bouum-Myunyuk-Dan. Biol Pharm Bull, 27, 29-33   DOI   ScienceOn
6 Kapur, S., Picard, F., Perreault, M., Deshaies, Y. and Marette, A. (2000) Nitric oxide: a new player in the modulation of energy metabolism. Int J Obes Relat Metab Disord, 24 Suppl 4, S36-40   DOI
7 Tracey, K.J. and Cerami, A. (1994) Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med, 45, 491-503   DOI   ScienceOn
8 Balsiger, B.M., Murr, M.M., Poggio, J.L. and Sarr, M.G. (2000) Bariatric surgery. Surgery for weight control in patients with morbid obesity. Med Clin North Am, 84, 477-489   DOI   ScienceOn
9 Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L. and Ferrante, A.W., Jr. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest, 112, 1796-1808   DOI
10 Xie, Q.W., Cho, H.J., Calaycay, J., Mumford, R.A., Swiderek, K.M., Lee, T.D., Ding, A, Troso, T. and Nathan, C. (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science, 256, 225-228   DOI
11 Connelly, L., Palacios-Callender, M. Ameixa, C., Moncada, S. and Hobbs, A.J. (2001) Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide. J Immunol, 166, 3873-3881   DOI
12 Das UN. (2001) Is obesity an inflammatory condition? Nutrition 17, 953-966   DOI   ScienceOn
13 Dietrich M, Jialal I. (2005) The effect of weight loss on a stable biomarker of inflammation, C-reactive protein. Nutr Rev, 63, 22-28   DOI
14 Kim, S.J., Jeong, H.J., Lee, K.M., Ryu, H.H., Lee, K.S., Moon, B.S., Cho, K.H. and Kim, H.M. (2005) Zingansikpoongtang modulates beta-amyloid and IL-I beta-induced cytokine production and cyclooxygenase-2 expression in human astrocytoma cells U373MG. J Ethnopharmacol, 96, 279-285   DOI   ScienceOn
15 Furuyashiki, T, Nagayasu, H., Aoki, Y, Bessho, H., Hashimoto, T, Kanazawa, K and Ashida, H. (2004) Tea catechin suppresses adipocyte differentiation accompanied by down-regulation of PPARgamma2 and C/EBPalpha in 3T3-Ll cells. Biosci Biotechnol Biochem, 68, 2353-2359   DOI   ScienceOn
16 Hauner H. (2004) The new concept of adipose tissue function. Physiol Behav, 83, 653-658   DOI   ScienceOn
17 Hotamisligil, G.S., Amer, P., Caro, J.F., Atkinson, R.L. and Spiegelman, B.M. (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest, 95, 2409-2415   DOI   ScienceOn
18 Kiseleva, E.P., Puzyreva, V.P., Ogurtsov, R.P. and Kovaleva, I.G. (2002) Effect of hyperlipidemia on functional activity of peritoneal macrophages in CBA and C57Bl/6 mice. Bull Exp Biol Med, 134, 288-290   DOI   ScienceOn
19 Linton, M.F. and Fazio, S. (2003) Macrophages, inflammation, and atherosclerosis. Int J Obes Relat Metab Disord, 27 Suppl 3, S35-40   DOI
20 Lamas O, Moreno-Aliaga MJ, Martinez JA, Marti A (2003) NF-kappa B-binding activity in an animal diet-induced over-weightness model and the impact of subsequent energy restriction. Biochem Biophys Res Commun. 311, 533-539   DOI   ScienceOn
21 Nathan, C. (1992) Nitric oxide as a secretory product of mammalian cells. Faseb J, 6, 3051-3064   DOI
22 Petros, A., Bennett, D. and Vallance, P. (1991) Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet, 338, 1557-1558   DOI   ScienceOn